Skip to main content

Table 3 VTEs in different treatment phases and Grades according to CTCAE v4.0

From: High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

Grade

Overall % (N = 29)

Preoperative CT & CRT % (N = 21a)

Postoperative % (N = 8)

G1

0% (0)

0% (0)

0% (0)

G2

45% (13)

52% (11)

25% (2)

G3

45% (13)

48% (10)

38% (3)

G4

0% (0)

0% (0)

0% (0)

G5

10% (3)

0% (0)

38% (3)

  1. Abbreviations: G Grade, CTCAE Common Toxicity Criteria for Adverse Events
  2. aOne patient had two separate VTEs in the RCT phase
Back to article page